GALDY
GALDERMA GROUP AG
40.96
-1.03-2.45%
Dec 16, 4:00:00 PM EST

Upcoming Earnings 

Report date
-/-

Earnings Call Transcripts

This Quarter (Q4 '25)

No earnings call transcript available yet

Last Quarter (Q3 '25)

No earnings call transcript available

Key Stats

Market Cap
48.09B
P/E (TTM)
128.00
Basic EPS (TTM)
0.32
Dividend Yield
0%

About 

Galderma Group AG operates as a dermatology company worldwide. The company delivers a science-based portfolio of brands and services for the dermatology market, including injectable aesthetics, dermatological skincare, and therapeutic dermatology. Its portfolio of flagship brands includes ACTINICA, Azzalure, ALLUZIENCE, Dysport, Restylane, Restylane Skinboosters, Sculptra, Cetaphil, ALASTIN, Soolantra, Epiduo, Epiduo Forte, Differin, AKLIEF, Oracea, Metvix, Mirvaso, NEMLUVIO, Relfydess, Benzac, Loceryl, and TRI-LUMA in therapeutic dermatology. The company was founded in 1981 and is headquartered in Zug, Switzerland.

CEO
Dr. Flemming Ornskov M.B.A., M.D., M.P.H.
IPO
7/8/2024
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic